KELSEY DARDEN: Open Payments
NPI 1144716945 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,256 in 48 payments from 19 companies in 2025. Trend: 2023 $1,551 · 2024 $1,936 · 2025 $1,256
Food & beverage: $1,256
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $255 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $240 |
| AstraZeneca Pharmaceuticals LP | 3 | $198 |
| Amgen Inc. | 2 | $103 |
| Novo Nordisk Inc | 4 | $97 |
| Alnylam Pharmaceuticals Inc. | 3 | $78 |
| PFIZER INC. | 3 | $50 |
| BridgeBio Pharma, Inc. | 1 | $30 |
| ABBVIE INC. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
Products named: LEQVIO, LifeVest, LOKELMA, REPATHA, Wegovy, ONPATTRO, FARXIGA, ELIQUIS.
Industry payments across SC — which companies pay providers there.
